Sfoglia per Rivista
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells.
2012-01-01 Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R.
Plasticità della cellule staminali mesenchimali
2005-01-01 MARESCHI K; NOVARA N; RUSTICHELLI D; GUIDO D; GARBOSSA D; MEREUTA M; CARBONE E; MADON E; VERCELLI A; FAGIOLI F.
Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy.
2003-01-01 VISCOMI S; PASTORE G; MOSSO ML; TERRACINI B; MADON E; MAGNANI C; MERLETTI F
Positive and negative signals in the control of myelopoiesis.
1989-01-01 AGLIETTA M
POST INDUCTION WT1 VALUES AND WT1 ONSET/POST INDUCTION RATIO ARE USEFULL TO STRATIFY ACUTE MYELOID LEUKEMIA PATIENTS
2016-01-01 Coluzzi, S. ; Introcaso, T; Iallorenzi, P.; Di Nardo, E.; Pascale, S.P.; Nuccorini, R.; Attolico, I.; Matturro, A.; Amendola, A.; Cimminiello, M.; Vertone, D.; Filardi, N.; Pizzuti, M.
Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant
2016-01-01 Ruggeri, Annalisa; Sun, Yuqian; Labopin, Myriam; Bacigalupo, Andrea; Lorentino, Francesca; Arcese, William; Santarone, Stella; Gülbas, Zafar; Blaise, Didier; Messina, Giuseppe; Ghavamzadeh, Ardeshi; Malard, Florent; Bruno, Benedetto; Diez-Martin, Jose Luis; Koc, Yener; Ciceri, Fabio; Mohty, Mohamad; Nagler, Arnon
Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia?
2019-01-01 Saglio, Giuseppe; Fava, Carmen; Gale, Robert Peter
Pregnancy and beta-thalassemia: an Italian multicenter experience
2010-01-01 R. Origa; A. Piga; G. Quarta; G. L. Forni; F. Longo; A. Melpignano; R. Galanello
Present results and future perspectives in optimizing chronic myeloid leukemia therapy
2018-01-01 Carella, Angelo M.; Saglio, Giuseppe; Mahon, Xavier F.; Mauro, Michael J.
Primary gastric lymphoma: distribution and clinical relevance of different epidemiological factors
1994-01-01 Fagioli, F; Rigolin, G M; Cuneo, A; Scapoli, G; Spanedda, R; Cavazzini, P; Castoldi, G
Primitive hematopoietic stem cells show a polyclonal pattern in myelodysplastic syndromes
2004-01-01 GUIDETTI F; GRAZIOLI S; CAPELLI F; MARINI C; GALLICCHIO M; DE MICHELI D; CASTELLO L; SAINAGHI PP; FRA GP; SAGLIO G; AVANZI GC
[Prognostic factors in multiple myeloma]
1989-01-01 BOCCADORO M ;BIANCHI A ;DIANZANI U ;FRIERI R ;GALLONE G ;MASSAIA M ;OMEDE P ;PALUMBO A ;PILERI A
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloidleukemia.
2008-01-01 Lo-Coco F; Cuneo A; Pane F; Cilloni D; Diverio D; Mancini M; Testoni N; Bardi A; Izzo B; Bolli N; La Starza R; Fazi P; Iacobelli S; Piciocchi A; Vignetti M; Amadori S; Mandelli F; Pelicci PG; Mecucci C; Falini B; Saglio G; Acute Leukemia Working Party of the GIMEMA group.
Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patients
2006-01-01 SIZZANO F; MAGISTRONI P; LOCATELLI F; BUSCA A; FALDA M; AFFATICATI P; MAZZOLA G; DALLOMO AM; AMOROSO A
Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia
2006-01-01 L. CHIUSA; P. FRANCIA DI CELLE; P. CAMPISI; C. CERETTO; F. MARMONT; A. PICH
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome
2011-01-01 Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M
Prolonged molecular remission in a late chronic phase CML patient after discontinuation of Imatinib Treatment.
2006-01-01 Rege-Cambrin G; Fava C; Mattioli G; Giugliano E; Gottardi E; Fava M; Ulisciani S; Scaravaglio P; Saglio G.
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
2019-01-01 Bruna R.; Benedetti F.; Boccomini C.; Patti C.; Barbui A.M.; Pulsoni A.; Musso M.; Liberati A.M.; Gini G.; Castellino C.; Rossini F.; Ciceri F.; Rota-Scalabrini D.; Stelitano C.; Di Raimondo F.; Tucci A.; Devizzi L.; Zoli V.; Zallio F.; Narni F.; Dondi A.; Parvis G.; Semenzato G.; Lanza F.; Perrone T.; Angrilli F.; Billio A.; Gueli A.; Mantoan B.; Rambaldi A.; Massimo Gianni A.; Corradini P.; Passera R.; Ladetto M.; Tarella C.
PROLONGED THERAPY WITH BORTEZOMIB PLUSMELPHALAN-PREDNISONE (VMP) RESULTS IN IMPROVED QUALITYAND DURATION OF RESPONSE IN THE PHASE III VISTA STUDY INPREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM)
2008-01-01 A. Palumbo; R. Schlag; N. Khuageva; O. Shpilberg; M. Dimopoulos; M. Kropff; I. Spicka; M. Petrucci; M. Delforge; M. Mateos; D. Esseltine; K. Liu; W. Deraedt; H. Van de Velde; P. Richardson; J. San-Miguel10
Proto-oncogene activation in human hematologic malignancies.
1986-01-01 SAGLIO G ;GUERRASIO A ;GAVOSTO F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. | 2012 | Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R. | |
| Plasticità della cellule staminali mesenchimali | 2005 | MARESCHI K; NOVARA N; RUSTICHELLI D; GUIDO D; GARBOSSA D; MEREUTA M; CARBONE E; MADON E; VERCELLI A; FAGIOLI F. | |
| Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. | 2003 | VISCOMI S; PASTORE G; MOSSO ML; TERRACINI B; MADON E; MAGNANI C; MERLETTI F | |
| Positive and negative signals in the control of myelopoiesis. | 1989 | AGLIETTA M | |
| POST INDUCTION WT1 VALUES AND WT1 ONSET/POST INDUCTION RATIO ARE USEFULL TO STRATIFY ACUTE MYELOID LEUKEMIA PATIENTS | 2016 | Coluzzi, S. ; Introcaso, T; Iallorenzi, P.; Di Nardo, E.; Pascale, S.P.; Nuccorini, R.; Attolico, I.; Matturro, A.; Amendola, A.; Cimminiello, M.; Vertone, D.; Filardi, N.; Pizzuti, M. | |
| Post-transplant cyclophosphamide versus antithymocyte-globulin as graft versus host disease prophylaxis in haploidentical transplant | 2016 | Ruggeri, Annalisa; Sun, Yuqian; Labopin, Myriam; Bacigalupo, Andrea; Lorentino, Francesca; Arcese, William; Santarone, Stella; Gülbas, Zafar; Blaise, Didier; Messina, Giuseppe; Ghavamzadeh, Ardeshi; Malard, Florent; Bruno, Benedetto; Diez-Martin, Jose Luis; Koc, Yener; Ciceri, Fabio; Mohty, Mohamad; Nagler, Arnon | |
| Precision tyrosine kinase inhibitor dosing in chronic myeloid leukemia? | 2019 | Saglio, Giuseppe; Fava, Carmen; Gale, Robert Peter | |
| Pregnancy and beta-thalassemia: an Italian multicenter experience | 2010 | R. Origa; A. Piga; G. Quarta; G. L. Forni; F. Longo; A. Melpignano; R. Galanello | |
| Present results and future perspectives in optimizing chronic myeloid leukemia therapy | 2018 | Carella, Angelo M.; Saglio, Giuseppe; Mahon, Xavier F.; Mauro, Michael J. | |
| Primary gastric lymphoma: distribution and clinical relevance of different epidemiological factors | 1994 | Fagioli, F; Rigolin, G M; Cuneo, A; Scapoli, G; Spanedda, R; Cavazzini, P; Castoldi, G | |
| Primitive hematopoietic stem cells show a polyclonal pattern in myelodysplastic syndromes | 2004 | GUIDETTI F; GRAZIOLI S; CAPELLI F; MARINI C; GALLICCHIO M; DE MICHELI D; CASTELLO L; SAINAGHI PP; FRA GP; SAGLIO G; AVANZI GC | |
| [Prognostic factors in multiple myeloma] | 1989 | BOCCADORO M ;BIANCHI A ;DIANZANI U ;FRIERI R ;GALLONE G ;MASSAIA M ;OMEDE P ;PALUMBO A ;PILERI A | |
| Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloidleukemia. | 2008 | Lo-Coco F; Cuneo A; Pane F; Cilloni D; Diverio D; Mancini M; Testoni N; Bardi A; Izzo B; Bolli N; La Starza R; Fazi P; Iacobelli S; Piciocchi A; Vignetti M; Amadori S; Mandelli F; Pelicci PG; Mecucci C; Falini B; Saglio G; Acute Leukemia Working Party of the GIMEMA group. | |
| Prognostic value of donor cytotoxic T-lymphocyte precursor frequencies for acute graft-versus-host disease in hematopoietic stem cell transplantation from HLA-matched siblings: a single center experience in a cohort of 92 patients | 2006 | SIZZANO F; MAGISTRONI P; LOCATELLI F; BUSCA A; FALDA M; AFFATICATI P; MAZZOLA G; DALLOMO AM; AMOROSO A | |
| Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia | 2006 | L. CHIUSA; P. FRANCIA DI CELLE; P. CAMPISI; C. CERETTO; F. MARMONT; A. PICH | |
| Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome | 2011 | Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M | |
| Prolonged molecular remission in a late chronic phase CML patient after discontinuation of Imatinib Treatment. | 2006 | Rege-Cambrin G; Fava C; Mattioli G; Giugliano E; Gottardi E; Fava M; Ulisciani S; Scaravaglio P; Saglio G. | |
| Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | 2019 | Bruna R.; Benedetti F.; Boccomini C.; Patti C.; Barbui A.M.; Pulsoni A.; Musso M.; Liberati A.M.; Gini G.; Castellino C.; Rossini F.; Ciceri F.; Rota-Scalabrini D.; Stelitano C.; Di Raimondo F.; Tucci A.; Devizzi L.; Zoli V.; Zallio F.; Narni F.; Dondi A.; Parvis G.; Semenzato G.; Lanza F.; Perrone T.; Angrilli F.; Billio A.; Gueli A.; Mantoan B.; Rambaldi A.; Massimo Gianni A.; Corradini P.; Passera R.; Ladetto M.; Tarella C. | |
| PROLONGED THERAPY WITH BORTEZOMIB PLUSMELPHALAN-PREDNISONE (VMP) RESULTS IN IMPROVED QUALITYAND DURATION OF RESPONSE IN THE PHASE III VISTA STUDY INPREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM) | 2008 | A. Palumbo; R. Schlag; N. Khuageva; O. Shpilberg; M. Dimopoulos; M. Kropff; I. Spicka; M. Petrucci; M. Delforge; M. Mateos; D. Esseltine; K. Liu; W. Deraedt; H. Van de Velde; P. Richardson; J. San-Miguel10 | |
| Proto-oncogene activation in human hematologic malignancies. | 1986 | SAGLIO G ;GUERRASIO A ;GAVOSTO F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile